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Key Points 
Question: Severe acute contact dermatitis (ACD) to Nigella sativa oil (NSO) after topical use 
is misdiagnosed. Histological findings are poorly described.  
Findings: We describe 6 patients who displayed clinical and histopathological features of 
epidermal necrolysis after NSO skin application. Analysis of the NSO showed thymoquinone 
and p-cymene as major components. 
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Meaning: Acute epidermal apoptotic necrolysis may be triggered by topical agents such as 
NSO. 
Abstract 
Importance: Nigella sativa oil (NSO) is widely used. Acute contact dermatitis to NSO is 
poorly described and lack histological description.  
Objective: To describe clinical and histological features of severe acute contact dermatitis 
(ACD) to NSO. To investigate the component(s) responsible for such eruption.  
Design: Series of six cases admitted in the dermatology department between 2010 and 2016.  
Setting: Monocenter, retrospective case series. 
Participants: All patients referred in our department for ACD to NSO.  
Main outcomes: We collected clinical and histological features of the cutaneous eruption, 
whether patients were hospitalized or not, treatment, length of stay, chemical analysis of NSO 
and results of patch tests when performed. 
Results: Six patients (all female, median age 29 years) were included. None of them had oral 
intake of NSO. All patients had polymorphic skin lesions spreading over the area of 
application: target and target-like lesions (n=6), patches with central blisters (n=5), 
erythematous or purpuric plaques with positive Nikolsky sign (n=5) mimicking epidermal 
necrolysis, and pustules (n=3). Three patients had severe impairment with more than 15 % 
skin detachment and fever. Skin biopsies (n=4) showed vacuolar alteration of the basal layer, 
keratinocytes apoptosis and a moderate perivascular infiltrate of lymphocytes in the dermis. 
Patch-tests using patient’s NSO were all positive. Gas chromatography combined to mass 
spectrometry (n=1) identified several constituent substances, mainly terpenes, thymoquinone, 
linoleic acid and fatty acids.  
Conclusions and relevance:  Our patients illustrate that epidermal necrolysis can be triggered 
by topics. They present features of hyperacute apoptotic injury of the epidermis, within the 
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spectrum of Acute Syndrome of Apoptotic Pan-epidermolysis. Thymoquinone and p-cymene 
being the main constituents could be involved in the pathophysiology of this ACD to topical 
application of NSO. Clinicians should be aware of these severe cutaneous adverse events of 
NSO, and declare any severe cases to a pharmacovigilance center.  
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Introduction 
Nigella sativa oil (NSO), extracted from the plant Nigella sativa found in South Europe, 
North Africa and South-West Asia, is traditionally used for cosmetic and culinary properties.
1
 
Its main components are thymoquinone and terpenes
1
, however, the exact composition of 
commercial NSO and proportion of its constituents are hardly predictable. NSO, and more 
generally essential oils, are known to be responsible for benign occupational contact 
dermatitis, but sometimes acute contact dermatitis (ACD).
2
  
Acute Syndrome of Apoptotic Pan-epidermolysis (ASAP) phenomenon, characterized by a 
hyperacute apoptotic injury of the epidermis, has been described in various dermatoses.
3
 The 
main cause is epidermal necrolysis (EN) spectrum, including Stevens-Johnson (SJS) and toxic 
epidermal necrolysis (TEN), induced by systemic drugs in most cases.
4
 Other causes of ASAP 
include TEN-like acute graft versus host disease, TEN-like acute and subacute cutaneous 
lupus erythematous, severe eruptions associated with Mycoplasma pneumoniae infection.
5
  
We report a series of 6 cases of severe ACD to NSO, showing polymorphic severe lesions 
mimicking erythema multiforme, bullous fixed drug eruption or EN, and, histologically, 
apoptotic epidermis, raising the hypothesis that ASAP could be topically-triggered by such 
essential oil.  
 
Methods 
We performed a retrospective monocenter study including consecutive patients referred to our 
Dermatology Department between 2010 and 2016 for dermatitis after NSO application. Cases 
were extracted from the database of our Department, which is a referral center for toxic 
bullous dermatoses.  
For each case, the following parameters were collected from the charts: age, sex, previous 
application of NSO, oral take of NSO, duration and localization of the application, time 
5 
 
between application and onset of cutaneous reaction, localization and extension of skin 
lesions, clinical aspect of skin lesions, mucous involvement, number of cutaneous flares, 
length of hospital stay, histologic analysis when skin biopsy was available, treatment and 
evolution, results of patch tests whenever performed. We investigated the composition of one 
of the patients’ NSO by gas chromatography (Chromatograph Trace GC Ultra) combined to 
mass spectrometry (Spectrometer Thermo Fisher TSQ Quantum).  
 
Results  
All cases were women with a median age of 29 years (range 20-47), who applied NSO in 
different parts of skin or scalp for cosmetic use only. None of them had oral intake of NSO 
(Table 1). Median time between application of NSO and onset of the disease was 1.5 days 
(range 1-2). Three patients had already used NSO before without cutaneous reaction. Clinical 
examination showed polymorphic skin lesions, spreading over the area of application (Fig.1): 
target and atypical targets (n=6), patches with central blisters (n=5), erythematous and 
purpuric macules and plaques with Nikolsky’s sign (n=5), and pustules (n=3). Three patients 
had severe impairment with more than 15 % of the body surface area involved with Nikolsky 
sign, fever and hospital length of stay of more than 10 days. One patient had a second 
cutaneous flare of the same lesions after washing her hair where she had initially applied 
NSO. 
Histology of a skin biopsy was performed in 4 cases and revealed in all cases vacuolar 
alteration of the basal layer, keratinocytes apoptosis and a moderate perivascular infiltrate of 
lymphocytes in the dermis (Fig.2). Three patients healed with post inflammatory 
hypopigmentation and hyperpigmentation. 
Three patients underwent patch-tests using their own NSO diluted at 1 % and all were positive 
at 96 hours. Gas chromatography-mass spectrometry performed in NSO of patient n°6 
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showed that the chemical composition of the oil was a complex mixture with p-cymene, 
thymoquinone, longofilene, linoleic acid and fatty acids as main components.  
 
Discussion  
We report 6 cases of severe and extensive ACD after topical use of NSO without oral intake, 
clinically mimicking erythema multiforme, bullous fixed drug eruption and EN, and 
histologically showing apoptotic epidermis as previously described in erythema multiforme 
and EN.
6
 The severity of our cases suggests a systemic effect of NSO inducing an extension 
of the lesions away from the area of application.   
ASAP, a syndrome characterized by hyperacute apoptotic injury of the epidermis, comprises 
various severe dermatoses such as EN (most often induced by systemic drugs
4
),TEN-like 
acute graft versus host disease, TEN-like acute and subacute cutaneous lupus erythematous, 
severe eruptions associated with Mycoplasma pneumoniae infections.
3,5
 ASAP probably 
results from the expression of various effector activation leading to the same massive 
keratinocytes death.
3
  
Our series illustrate that ASAP could also be triggered by topics such as NSO. In our cases, 
clinical and histological presentation mimics such ASAP phenomenon, but is topically-
triggered by NSO, maybe followed by a systemic diffusion that could explain the extension of 
the lesions. Such severe erythema multiform-like and TEN-like eruptions have already been 
described after contact with NSO
7,8 
and also with other essential oil
9,10
 (tea tree oil, iron wood 
trees, poison ivy…).  
The market (often web-market) of these frequently not pure oils is not controlled and the 
component concentration is uncertain. The constituents of NSO were previously described 
showing the presence of thymoquinone and p-cymene as in our case.
1,11
 Thymoquinone is 
investigated for therapeutic uses in neurology and oncology thanks to its antioxidant, anti-
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inflammatory and supposed anti-neoplastic and pro-apoptotic properties. 
12–15
 p-Cymene is a 
monoterpene which acts as penetration enhancer by disrupting the stratum corneum lipid 
structure, thus facilitating the transport of drugs through the skin.
16,17
 NSO contains 
thymoquinone and p-cymene in often unknown variable proportion. Synergy of p-cymene and 
thymoquinone might promote ASAP, by an additional effect of a toxic topical effect and 
systemic diffusion.  
 
Conclusion 
Clinicians and patients should be aware of the possibility of severe cutaneous adverse events 
of NSO. Components of NSO should be labeled and their proportions should be better 
defined. The web-market needs to be better controlled. Severe cases should be declared to the 
pharmacovigilance.   
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Figure 1: cutaneous eruption with large blisters (arrow), Nikolsky sign (star), atypical targets 
(arrow-head) and patches with central blisters (sharp). 
 
* 
* 
# 
# 
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Figure 2: histological analysis of skin biopsy in HES staining: vacuolar alteration of the 
basal layer (arrow-head), keratinocytes apoptosis (arrow) and perivascular infiltrate of 
lymphocytes (star) 
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Table 1: Characteristics of 6 patients seen in the Dermatology Department for a skin reaction following application of NSO  
Patient 
Sexe 
/ 
Age 
NSO use 
Time to 
onset 
(days) 
Fever 
Clinical aspects 
Number 
of flare 
Length of 
hospital stay 
(days) 
Allergologic investigation 
Area of 
application 
Previous  
use / 
reaction 
Body 
surface 
(%) 
Area 
involved 
Skin 
lesions 
Extension 
over area 
of 
applicaiton 
Mucous 
involvement 
Tested products Score* 
1 
F / 
47 
Left hand 
Stomach 
None / - 2 Yes Unknown 
Scalp 
Stomach 
Forearms 
Hands 
Thighs 
Patches 
Blisters 
Atypical 
targets 
Yes None 1 10 Patient's NSO 1 
2 
F / 
22 
Ear None / - 1 No 12 
Face 
Torso 
Stomach  
Thighs 
Patches 
Blisters 
Typical 
targets 
Pustules 
Yes None 1 3 NP - 
3 
F / 
26 
Hair and 
scalp 
Unknown 
/ - 
Unknown No 7 
Forearms 
Hands 
Knees 
Patches 
Typical 
targets 
Yes Unknown 1 0 NP - 
4 
F/ 
20 
Face 
Yes / 
None 
2 Yes 40 
Face 
Torso 
Forearms 
Blisters 
Atypical 
targets 
Pustules 
Yes None 1 10 
Patient's NSO 
limonene 
hydroperoxyde 
linalool 
hydroperoxyde 
camomille extract 
achileamillefolium 
Laurier essence 
3 
2 
 
2 
 
2 
2 
1 
5 
F / 
29 
Hair and 
scalp 
Unknown 
/ - 
Unknown No 18 
Scalp 
Face 
Neck 
Back 
Patches 
Blisters 
Typical 
targets 
Yes None 1 0 NP - 
6 
F / 
27 
Hair and 
scalp 
Yes / 
None 
1 Yes 30 
Scalp  
Face 
Torso 
Stomach 
Back 
Forearms 
Hands 
Elbows 
Pubis  
Thighs 
Patches 
Blisters 
Atypical 
targets 
Pustules 
Yes conjuntivitis 2 10 Patient’s NSO 1 
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NSO: Nigella sativa oil; NP : not performed ; * : according to the International Contact Dermatitis Research Group Score for epicutaneous tests 
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